Skip Navigation

Publication Detail

Title: Multifunctional Polymer-Coated Carbon Nanotubes for Safe Drug Delivery.

Authors: Moore, Thomas L; Pitzer, Joshua E; Podila, Ramakrishna; Wang, Xiaojia; Lewis, Robert L; Grimes, Stuart W; Wilson, James R; Skjervold, Even; Brown, Jared M; Rao, Apparao; Alexis, Frank

Published In Part Part Syst Charact, (2013 Apr)

Abstract: Though progress in the use carbon nanotubes in medicine has been most encouraging for therapeutic and diagnostic applications, any translational success must involve overcoming the toxicological and surface functionalization challenges inherent in the use of such nanotubes. Ideally, a carbon nanotube-based drug delivery system would exhibit low toxicity, sustained drug release, and persist in circulation without aggregation. We report a carbon nanotube (CNT) coated with a biocompatible block-co-polymer composed of poly(lactide)-poly(ethylene glycol) (PLA-PEG) to reduce short-term and long-term toxicity, sustain drug release of paclitaxel (PTX), and prevent aggregation. The copolymer coating on the surface of CNTs significantly reduces in vitro toxicity in human umbilical vein endothelial cells (HUVEC) and U-87 glioblastoma cells. Moreover, coating reduces in vitro inflammatory response in rat lung epithelial cells. Compared to non-coated CNTs, in vivo studies show no long-term inflammatory response with CNT coated with PLA-PEG (CLP) and the surface coating significantly decreases acute toxicity by doubling the maximum tolerated dose in mice. Using polymer coatings, we can encapsulate PTX and release over one week to increase the therapeutic efficacy compared to free drugs. In vivo biodistribution and histology studies suggests a lower degree of aggregation in tissues in that CLP accumulate more in the brain and less in the spleen than the CNT-PLA (CL) formulation.

PubMed ID: 27642231 Exiting the NIEHS site

MeSH Terms: No MeSH terms associated with this publication

Back
to Top